Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2020

Aug 21, 2020

32601_dirs_2020-08-21_7adcd8a3-58ab-496b-9e09-bbb929ffe39a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-08-19

Reporting Person: Spiess Bernhard E. (Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-19 Common Stock S 20000 $45 Disposed 105626 Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 18, 2020.